Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RELI - Need to keep an eye on this one. Several catalysts coming in March and CEO plans to up list to Nasdaq this year (no reverse split needed)
$INO booom
INO looking very strong!
$INO Inovio plans to rapidly develop INO-4800 against the new coronavirus and has already started preclinical testing and preparations for clinical product manufacturing. The goal of this collaboration is to leverage Advaccine's expertise to run a Phase 1 trial in China in parallel with Inovio's clinical development efforts in the U.S. Inovio and Advaccine will also work together to attract additional grant funding and further collaborations with larger vaccine companies in China to increase the speed of future testing of INO-4800.
$INO Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China https://www.prnewswire.com/news-releases/inovio-collaborating-with-beijing-advaccine-to-advance-ino-4800-vaccine-against-new-coronavirus-in-china-300995916.html
Folks we have a birth from a shell in progress that in 4 weeks or less will be all the talk of the town, biotech wise.
Name already changed to NDT Pharmaceuticals inc.
Several living legends, Professor Michael W Fountain, Dr. Dorsey and Dr. Coven, 2 University and hospital research centers UPennMed and Childredns Hospital all have been working for years on how tio use Lipsomes to cross the BBB-Blood Brain Barrier and are now taking that JV Research public.
Ibox is updated, fillings and R/M completion is due before or on March 12th. But looks at what they have and are bringing.
Market cap of the float is barely 1 Mil dollars. Once news hits 300 Mil Plus is possible!
Any questions PM or reply to this message as I have 500,000 pages and 4 months of DD behind this one I am ready to share.
More key DD is all here:
https://ccabiotech.blogspot.com/p/patent.html
https://ccabiotech.blogspot.com/p/members.html
https://ccabiotech.blogspot.com
https://ccabiotech.blogspot.com/home
Here is what we know they have already:
$CVSI BDS Analytics estimates that U.S. sales of cannabis and hemp-derived CBD product is expected to surge from $1.9 billion in 2018 to $20 billion by 2024, a compound annual growth rate of 49%. According to their research, there is substantial consumer interest in the consumables (tinctures, pills, beverages, food) and Topicals (creams, balms, salves) formats, despite the current low consumer penetration rate. In addition, many major national retailers (CVS, Walgreens, Rite Aid, Sprouts, Whole Foods, Ulta, GNC Holdings, Designer Brands, Urban Outfitters, and Neiman Marcus) have been early adopters of CBD topical products and have introduced various product lines in select markets.
$BNGO The 2 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +197.03% increase from the last price of 1.01. https://money.cnn.com/quote/forecast/forecast.html?symb=bngo
ok... follow me on twitter
$BNGO The 2 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +188.46% increase from the last price of 1.04. https://money.cnn.com/quote/forecast/forecast.html?symb=BNGO
$CVSI The 3 analysts offering 12-month price forecasts for CV Sciences Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +164.03% increase from the last price of 1.52.
https://money.cnn.com/quote/forecast/forecast.html?symb=cvsi
i bought yesterday at 0.80 and sold all on pops! please check my twitter so, you will know what i'm doing :)
$BNGO Professor from Emory University School of Medicine used the Saphyr system to study a genetic syndrome characterized by intellectual disability, autism and a 40-fold increased risk for schizophrenia. She identified a high degree of previously undocumented structural variation in the disease region, identified a new gene previously not known to be involved in the disease, and was able to develop a new hypothesis about the disease mechanism from the data generated by Saphyr. http://www.globenewswire.com/news-release/2019/10/24/1934941/0/en/Takeaways-from-ASHG-2019-in-Houston-Users-of-Bionano-s-Saphyr-System-Presented-Validation-Results-for-FSHD-Repeat-Expansion-Disorders-and-Digital-Cytogenetics-Among-a-Growing-List-.html
Bionano Genomics, Inc. $BNGO is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company's products include Sequencing for Discovery Research and Cytogenetics. Sequencing alone, however, is significantly limited due to its inability to reveal structural variations. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response.
Company Contact
Headquarters
9540 Towne Centre Dr Ste 100
San Diego, CA 92121-1989
https://bionanogenomics.com/
$BNGO Professor at Baylor College of Medicine, who used data from the Saphyr system to analyze repeat-mediated inversions, which are complex genomic structures that are hard or impossible to resolve with other molecular methods but can predispose to genetic disease; Tina Graves-Lindsay from the McDonnell Genome Institute at Washington University, who corrected structural errors in the official human reference genomes with data generated with Saphyr; and Amir Trabelsi, CEO of Genoox, who announced the new release of a software pipeline that now automatically validates, annotates and classifies Bionano translocation calls from whole genome sequence data. http://www.globenewswire.com/news-release/2019/10/24/1934941/0/en/Takeaways-from-ASHG-2019-in-Houston-Users-of-Bionano-s-Saphyr-System-Presented-Validation-Results-for-FSHD-Repeat-Expansion-Disorders-and-Digital-Cytogenetics-Among-a-Growing-List-.html
$VBIV VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI is advancing the prevention and treatment of hepatitis B, with the only commercially-approved trivalent hepatitis B vaccine, Sci-B-Vac®, which is approved for use in Israel and 10 other countries and is currently in a Phase 3 program in the U.S., Europe, and Canada, and with an immunotherapeutic in development for a functional cure for chronic hepatitis B. VBI’s eVLP Platform technology allows for the development of enveloped virus-like particle (eVLP) vaccines that closely mimic the target virus to elicit a potent immune response. Integrating its cytomegalovirus (CMV) expertise with the eVLP platform technology, VBI’s lead eVLP program candidates include a prophylactic CMV vaccine candidate and a glioblastoma (GBM) vaccine immunotherapeutic candidate. VBI is headquartered in Cambridge, MA with research operations in Ottawa, Canada and research and manufacturing facilities in Rehovot, Israel.
$BNGO has $15.29 Million Cash Already on hand.
NTRR HAS UNLIMITED AUTHORIZED SHARE BUYER BEWARE!!
$NTRR New CBD product
$HEMP Industrial Hemp Consulting
Hemp, Inc.’s Industrial Hemp and Medical Marijuana Consulting Company (IHMMCC) was recently restructured as its ninth division and is now “Division Nine - Industrial Hemp Consulting”. With an influx of public companies wanting to expand into the industrial hemp industry, Hemp, Inc. has been inundated with potential consulting agreements. To keep up, Hemp, Inc. revamped its consulting division to work hands-on with each company to provide its years of expertise. According to Perlowin, there is definitely a sense of a “Community of Companies” whereby a lot of companies are working together to pool their resources, marketing connections and strategies in order to grow simultaneously.
Typically, companies seeking in depth consulting services from Hemp, Inc. pay mostly in stock since cash flow is oftentimes tight during the developmental stage of start-up companies in this industry. Through Hemp, Inc.’s Division Nine – Industrial Hemp Consulting, a wide range of services are forged from the experiences of creating the first publicly trading company in the cannabis sector (Medical Marijuana, Inc.) and having well over a decade of experience in the cannabis industry’s public sector. Perlowin, Hemp, Inc.’s chief executive officer also has over five decades in the industry itself. https://www.globenewswire.com/news-release/2019/08/30/1909261/0/en/Hemp-Inc-Announces-Credit-Unions-Now-Allowed-to-Offer-Services-to-Hemp-Industry-Businesses.html
$HEMP Industrial Hemp Investments and Joint Ventures
Hemp, Inc. recently established the eighth division (Industrial Hemp Investments and Joint Ventures). Since the passing of the hemp bill, Hemp, Inc. has been flooded with inquiries of people who want to invest in the hemp industry but don’t know where to start. As the Avant-guard of the industrial hemp industry, Hemp, Inc. has put together numerous joint venture investment opportunities for the medium to large-scale investor. Those who are interested should email ir@hempinc.com. Multi-million dollar, and in some cases billionaires and billion dollar hedge funds, are aggressively trying to get into the hemp industry since the passing of the 2018 Farm Bill. Our joint venture agreements are that they put up the money and we put up the expertise in a 50/50 revenue share. This will save the large-scale hemp investor two years and dozens of mistakes that they will make without an expert in the hemp industry. This is where Hemp, Inc.’s vast network and resources in the industrial hemp industry come into play because this is something that can easily be provided. https://www.globenewswire.com/news-release/2019/08/30/1909261/0/en/Hemp-Inc-Announces-Credit-Unions-Now-Allowed-to-Offer-Services-to-Hemp-Industry-Businesses.html
thank you for the info.
$HEMP The Hemp Educational Infrastructure
The Hemp Educational Infrastructure (Division Four) includes Hemp, Inc.'s Hemp University which focuses on educating and empowering Hemp farmers and entrepreneurs with knowledge, processing, infrastructure and support. The educational seminars, through the Hemp University, are held periodically and teach farmers and landowners how to create a profitable income stream by maximizing the per-acre crop revenue. Through this division, Hemp, Inc. has trained well over 500 farmers in its first two years by doing six Hemp University seminars in North Carolina.
In March 2019, Hemp, Inc. completed the first west coast Hemp University in Oregon, which helped educate attendees about the various opportunities that have become available for Southern Oregon residents and farmers. The all-day educational seminar brought like-minded people together to discuss and learn from experts in the trade.
With the exceptional response to the first west coast Hemp University, Hemp, Inc. held the second set of educational seminars in Oregon. This event was titled “Pre-Planting Support Workshop”, and was held May 4, 2019. This educational seminar was hosted prior to Oregon’s hemp planting season and was designed to educate attendees on planting, feminized seeds, clones, soil amendments, organic fertilizers and more. Vendors at this workshop had most of these items on sale just in time for the 2019 planting season.
The Hemp University seminars are intended to educate farmers, entrepreneurs or investors on how to grow a lucrative cash crop. For those interested in attending, presenting or showcasing at the next Hemp University, please contact Sophia Blanton at hempu@hempinc.com.
To see short videos of The Hemp University educational seminars, go to Bruce Perlowin’s Facebook page starting with the March 23, 2019 post and those following that date.
“Since The Hemp University’s initial launch with the educational symposium, the number of attendees has grown tremendously and it has been an overwhelming success, each time. The interactive, hands-on learning approach is invaluable. By learning in an interactive cohort format, students gain the necessary skills they need to immediately implement them on their farm or in their organization. It’s the perfect mix of quality instruction, relevant educational content and a high level of commitment, to ensure the educational success of each attendee,” said Perlowin.
Thus far, The Hemp University has helped transform the livelihoods of North Carolina and Oregon farmers transitioning from tobacco to industrial hemp, in North Carolina and from medical and recreational marijuana to industrial hemp in Oregon by providing them with the tools and support needed to gain a foothold in this burgeoning industry. https://www.globenewswire.com/news-release/2019/08/30/1909261/0/en/Hemp-Inc-Announces-Credit-Unions-Now-Allowed-to-Offer-Services-to-Hemp-Industry-Businesses.html
$MJNA Medical Marijuana
$HEMP Hemp Inc. Undervalued Hemp Pipeline http://www.hempinc.com
HPMM Hemp Naturals Inc.
Currently trading at $0.15
Very Low Float Hemp Stock
$KRUS ~ from yahoo poster Ted posted this 6 hours ago:
Kura Sushi was IPO in Taiwan stock market as well in June this year. The IPO price was NTD$32 and now it is NTD$127.
Hi lei thanks for this info and nice hearing from you! I see you on Twitter!
Have a great day!
Re: Eagle1 Post# 7451
hi Eagle :) very sorry for the late reply!
we are just fine - please follow us on twitter ... btw, i bought $KRUS yesterday at $15.75 and i added twice yesterday and i added more at open today! ~ new IPO yesterday ~ this one might go $35, even $50 ? ... not sure but i like tiny offering ~ i've been tweeting since it opened IPO... my best price is at low $15 ~ regret that i didn't go all in at open!
Report TOS
hi Eagle :) very sorry for the late reply!
we are just fine - please follow us on twitter ... btw, i bought $KRUS yesterday at $15.75 and i added twice yesterday and i added more at open today! ~ new IPO yesterday ~ this one might go $35, even $50 ? ... not sure but i like tiny offering ~ i've been tweeting since it opened IPO... my best price is at low $15 ~ regret that i didn't go all in at open!
HI Kei, where have you and ash been? Seems quite here now. MRKR made a nice run then dropped. It’s about to reset. Also added VBIV on this drop. Both are perspective plays.
$PRED... check the fundamentals. Leadership speaks for itself, take advantage of the imminent rebound at a minimum.
They have been tapping ATM.. we will know about their cash position from coming earnings in August.
CLSD. Have you had a look at their cash situation?
CLSD pdufa 10/19/19 - looks like it started going up .. $2 before the FDA decision is possible since market cap and float are very small.
Will do, thank you
OLTKW- warrants for Outlook Therapeutics. Strike $2.90- Oppenheimer just gave them a $12 target.
WSFT Is a new wiki company. Reverse merger in progress and OS is only 315 K. It appears heavily shorted and if they are going to be as big as Wikipedia, which the website indicates, I think it’s worth picking up.
its hard to buy since no volume at all - when the deal will come? thanks
YBIN- Billion dollar merger, all DD checks out. Department of defense contractor.
I don’t think so other than further trials. Maybe partnerships if this news is legit
Bitcoin is back (looks like) - i have small shares of $GBTC bought at $4.80 area ... this one hit $19 area a year ago ... so, i now have this like i don't own any shares.
does this one has near-term any catalyst? thanks.
$BPMX beautiful biotech pipeline https://www.biopharmx.com/pipeline/overview/
$VRRB - VERB Nasdaq Update News! We are Getting Close! $VERB WILL be new #NASDAQ symbol!
https://video.nfusz.com/player/6QAE8ZLK
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |